We are incredibly grateful for the Hale’s continuing partnership in advancing pancreatic cancer research and clinical care. With this transformational $50 million gift – one of the largest single gifts Dana-Farber Cancer Institute has received – Judith B. Hale, her son Robert T. Hale Jr., and his wife, Karen Hale…
Drs. Wolpin, Aguirre and Kimberly Perez, along with Tyler Jacks, Director of the Koch Institute contributed to the “Let’s Win Survivor Series”. Read the full story on “An Army of Investigators” and view the video here.
Today is World Pancreatic Cancer Day! At the Hale Center we took the opportunity to wear purple to commemorate the occasion. We believe in raising awareness and demanding better treatments for pancreatic cancer.
We were fortunate to have Will Hwang, M.D., Ph.D. (postdoctoral fellow in Dr. Tyler Jack’s and Aviv Regev’s labs at MIT) as an outside speaker today for Hale Center meeting. He gave a great presentation on single-cell RNA sequencing (scRNA-Seq) to identify new cell populations in pancreatic cancer.
Congratulations to Tom Clancy, M.D. who was awarded the Nobility in Science Award from the National Pancreas Foundation. Tom is co-leader of the Dana-Farber and Brigham and Women’s Pancreatic Cancer Center and works tirelessly for his patients. In addition, Tom is a fantastic Hale Center collaborator providing critical translational insights and clinical samples…
Dr. Brian Wolpin recently gave an update at the Lustgarten Foundation. He mentioned that work at the Hale Center has led to changes in clinical care and national movement for changes in guidelines for genetic testing.
Congratulations to Nathanael Gray who is the co-winner of the 2019 Paul Marks Prize!
A new paper was published in Cell Reports on the synthetic lethal relationship between SHOC depletion and MEK inhibition in RAS-driven cancers.
Today’s Hale Center speaker, Dr. David Pellman presented a wonderful talk on chromothripsis and chromatin bridges in pancreatic cancer.
Hale Center members were well represented at the AACR pancreatic cancer meeting in Boston. Here the members have assembled for lunch.